Impact Factor 3.845 | CiteScore 3.92
More on impact ›
in Pharmacology |
|
Submit your manuscript
Scope
We consider Translational Pharmacology as a two-way road: bench to bedside and bedside to bench.
Read more
Scope
The section Translational Pharmacology publishes original and review articles on the most outstanding advances across the spectrum of research that is undertaken to from drug discovery to market. We consider Translational Pharmacology as a two-way road: bench to bedside and bedside to bench. This concept, initiated in 2003 in translational medicine, is increasingly important in Pharmacological Research and Development. Articles for submission may present studies that validate drug targets or describe pharmacological characterization of known or novel compounds. The full suite of development activities is of interest, especially those concerning the relationship between pharmacokinetics and pharmacodynamics. Articles addressing safety, efficacy, toxicology and toxicokinetics are within the scope of the specialty section. Studies dealing with drug formulation and delivery may be considered when these are integrated with biological studies. This section has a specific interest in promoting the use of organ- and disease-on-a-chip and related 3 dimensional in vitro models of chronic diseases. Studies dealing with the application of mechanical inputs and outputs in assessment of drug actions, as well as those on agents impacting on cellular and molecular mechanics will be identified in an emerging sub-discipline of “Mechanopharmacology”. The overall goal of Translational Pharmacology is to build a research platform and to inform and educate the scientific community on current developments and approaches to translation of knowledge on drug targets into new medicines.
Indexed in: PubMed, PubMed Central, Scopus, Web of Science, Google Scholar, DOAJ, CrossRef, Chemical Abstracts Service (CAS)
PMCID: all published articles receive a PMCID
Translational Pharmacology welcomes submissions of the following article types: Case Report, Clinical Trial, Correction, Editorial, General Commentary, Hypothesis and Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Review, Specialty Grand Challenge and Technology and Code.
All manuscripts must be submitted directly to the section Translational Pharmacology, where they are peer-reviewed by the Associate and Review Editors of the specialty section.
Frontiers Editorial Office
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Switzerland
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
Frontiers Support
Tel +41(0)21 510 17 10
Fax +41 (0)21 510 17 01
support@frontiersin.org
There are no results to display.
Click on any of the keywords to find further editors related to it.
- Article(s) found
- Latest
- Most viewed
This section has no articles.
There are no articles to display. Please try changing the filters.
- Research Topic(s) found
- Latest
- Most viewed
Contact Editorial Office
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Switzerland
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
For all queries regarding manuscripts in Review and potential conflicts of interest, please contact pharmacology.editorial.office@frontiersin.org
For queries regarding Research Topics, Editorial Board applications, and journal development, please contact pharmacology@frontiersin.org
Tel +41(0)21 510 17 10
Fax +41 (0)21 510 17 01
For technical issues, please visit our Frontiers Help Center, or contact our IT HelpDesk team at support@frontiersin.org